Sign In
Buy MRTX
$58.70
+0 (+0%)
At Close: Apr 19, 2024
Mirati Therapeutics Inc (NASDAQ:MRTX) Shares Sold by Two Sigma Advisers LP
08:30am, Monday, 22'nd Jun 2020
Two Sigma Advisers LP lowered its position in shares of Mirati Therapeutics Inc (NASDAQ:MRTX) by 42.5% during the first quarter, according to the company in its most recent Form 13F filing with the SE
Geode Capital Management LLC Increases Stake in Mirati Therapeutics Inc (NASDAQ:MRTX)
07:43am, Monday, 22'nd Jun 2020
Geode Capital Management LLC raised its stake in Mirati Therapeutics Inc (NASDAQ:MRTX) by 15.3% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commiss
Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to developing and commercializing new medicines
Principal Financial Group Inc. Has $1.33 Million Stake in Mirati Therapeutics Inc (NASDAQ:MRTX)
05:48am, Saturday, 20'th Jun 2020
Principal Financial Group Inc. lifted its position in shares of Mirati Therapeutics Inc (NASDAQ:MRTX) by 15.9% during the 1st quarter, according to the company in its most recent 13F filing with the S
Stock Traders Purchase Large Volume of Mirati Therapeutics Put Options (NASDAQ:MRTX)
01:48am, Saturday, 20'th Jun 2020
Mirati Therapeutics Inc (NASDAQ:MRTX) saw unusually large options trading activity on Thursday. Stock investors purchased 1,094 put options on the company. This represents an increase of 1,926% compar
Morgan Stanley Bets on These 3 Hot Tech Stocks
03:00pm, Wednesday, 17'th Jun 2020
Last week was grim for the stock market, including the worst single-day loss since March, but the trend lines are turning upwards again this week. Treasury Secretary Mnuchin’s statement that the US
GSK pumps $120M into partnership with Ideaya in oncology precision medicine play
03:52pm, Tuesday, 16'th Jun 2020
The California-based company is developing drugs that work through "synthetic lethality," whereby they target two genes at once rather than only targeting one.
Nvidia, Intel stocks get downgraded at Morgan Stanley
02:09pm, Tuesday, 16'th Jun 2020
Morgan Stanley analyst Joseph Moore downgraded shares of Nvidia Corp. and Intel Corp. to equal weight from overweight Tuesday, writing that he's shifting his chip-sector preferences toward names tha
Agios up as FDA gives Thermo Fisher glioma test breakthrough status -
08:57am, Tuesday, 16'th Jun 2020
Shares in Agios Pharma ticked upwards after the FDA awarded breakthrough status to a companion diagnostic to vorasidenib,
Tumori: da Harvard a Torino per curare i polmoni - Piemonte
11:04am, Monday, 15'th Jun 2020
Da Boston a Torino per studiare i tumori ai polmoni con un finanziamento di 1 milione di dollari
della Fondazione Armenise Harvard. (ANSA)
The 7 Best Semiconductor Stocks on the Market Now
03:54pm, Friday, 12'th Jun 2020
Moore's Law says that the number of transistors on a silicon chip will double every two years. That premise of ever-expanding computing power has been the driving force behind the modern digital revol
Amgen, Inc. (AMGN) Presents at Goldman Sachs Healthcare Conference (Transcript)
09:57pm, Wednesday, 10'th Jun 2020
Amgen, Inc. (NASDAQ:AMGN) Goldman Sachs Healthcare Conference Call June 10, 2020 01:20 PM ET Company Participants Peter Griffith - EVP and CFO Dave Reese - EVP
